When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Gilead: Despite Its Recent Surge The Stock Did Not Reach Its Fair Value Yet
Bristol-Myers Squibb Company
Lately, interest for Gilead (GILD) stock has risen dramatically as a consequence of a potential launch of its COVID-19 drug named Remdesivir. I have been a long-term believer in this company. My investment thesis, also discussed in my December article, is based on three factors: its new management team, new longer term growth opportunities and significant undervaluation. Today, I want to reassess this investment thesis by discussing the impact of Remdesivir and other recent initiatives to create shareholder wealth. I believe that Gilead, led by a very competent new CEO, is undergoing